New investment by Neva SGR in Life Sciences and PropTech

The image accompanying the News on Neva SGR's investment in BetaGlue Technologies and Casavo, portrays two men in suits, sitting next to each other, consulting a tablet together on a desk where can also be glimpsed a laptop and a glass of water

Neva SGR, an Intesa Sanpaolo Group company wholly controlled by the Intesa Sanpaolo Innovation Center, through its Neva First Fund has made two investments in companies operating respectively in Life Sciences and PropTech:

BetaGlue Technologies, which has developed and patented an advanced radiotherapy platform for cancer treatments
Casavo, which buys and sells real estate with a unique, innovative business model integrating all players, including the banking industry.

The investment comes just a few weeks after another transaction, in the Cybersecurity sector, once again in support of the most innovative companies.

From August 2020 to date, the Neva First fund has exceeded €130 mln in allocated capital, of which more than €35 mln in Italy.

Last updated 1 August 2022 at 15:44:49